Patent · US Active

Polymorphs of an SSAO inhibitor

US11820754B2 · kind B2 · utility

0Cited by
11References
18Claims
0Family size

Assignee

Inventor

Key dates

Filing dateAug 24, 2021
Grant dateNov 21, 2023
Priority date—
Expiry dateAug 24, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided herein are polymorphs of (2E)-3-fluoro-2-({[2-(4-methoxypiperidin-1-yl)pyrimidin-5-yl]oxy}methyl)prop-2-en-1-aminium 4-methylbenzenesulfonate, compositions thereof, methods of preparation thereof, and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.